Patents by Inventor Holger Karsunky

Holger Karsunky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES SPECIFIC FOR CLL-1
    Publication number: 20130295118
    Abstract: Provided herein are antibodies specific for CLL-1.
    Type: Application
    Filed: March 11, 2013
    Publication date: November 7, 2013
    Applicant: Cellerant Therapeutics, Inc.
    Inventors: Ping Jiang, Holger Karsunky, Rob Tressler
  • Methods and compositions for enhancing engraftment of hematopoietic stem cells
    Patent number: 8383095
    Abstract: The present disclosure relates to the field of hematopoietic stem cell transplantation. More specifically, methods, compositions and kits for improving engraftment of stem cell transplants by administering myeloid progenitor cells are provided.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: February 26, 2013
    Assignee: Cellerant Therapeutics, Inc.
    Inventors: Julie Lynne Christensen, Holger Karsunky
  • ANTIBODIES THAT SPECIFICALLY BIND TO TIM3
    Publication number: 20130022623
    Abstract: Provided herein are antibodies specific for TIM3 that can be used to detect cancer cells, in particular, cancer stem cells. The antibodies can also be used in therapeutic compositions for treating cancer and reducing inflammation.
    Type: Application
    Filed: June 29, 2012
    Publication date: January 24, 2013
    Applicant: Cellerant Therapeutics, Inc.
    Inventors: Holger Karsunky, Ying-Ping Jiang
  • COMPOSITIONS AND METHODS FOR TREATING HAEMATOLOGICAL PROLIFERATIVE DISORDERS OF MEYLOID ORIGIN
    Publication number: 20110059852
    Abstract: The disclosure relates to methods and compositions effective in the diagnosis, prognosis and treatment of human hematopoietic cancers. In particular, the disclosure provides tumor-associated genes that encode for cytokine receptors that are differentially expressed in hematopoietic tumor cells of myeloid origin compared with other cells, e.g., normal stem cells.
    Type: Application
    Filed: March 26, 2009
    Publication date: March 10, 2011
    Applicant: Cellerant Therapeutics, Inc.
    Inventor: Holger Karsunky
  • Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof
    Publication number: 20110044894
    Abstract: The disclosure relates to methods and compositions effective in the diagnosis, prognosis and treatment of human hematopoietic cancers. In particular, the disclosure provides tumor-associated genes that encode for members of the immunoglobulin (Ig) and/or toll-like receptor superfamilies that are differentially expressed in hematopoietic tumor cells of myeloid origin compared with other cells, e.g., normal stem cells.
    Type: Application
    Filed: March 26, 2009
    Publication date: February 24, 2011
    Applicant: Cellerant Therapeutics, Inc.
    Inventor: Holger Karsunky
  • Methods and Compositions for Enhancing Engraftment of Hematopoietic Stem Cells
    Publication number: 20070237752
    Abstract: The present disclosure relates to the field of hematopoietic stem cell transplantation. More specifically, methods, compositions and kits for improving engraftment of stem cell transplants by administering myeloid progenitor cells are provided.
    Type: Application
    Filed: February 14, 2007
    Publication date: October 11, 2007
    Inventors: Julie CHRISTENSEN, Holger KARSUNKY